Abstract:Schizophrenia (SCZ) is a severe, highly heterogeneous psychiatric disorder with varied clinical presentations. The polygenic genetic architecture of SCZ makes identification of causal variants daunting. Gene expression analyses have shown that SCZ may result in part from transcriptional dysregulation of a number of genes. However, most of these studies took the commonly used approach—differential gene expression analysis, assuming people with SCZ are a homogenous group, all with similar expression levels for any given gene. Here we show that the overall gene expression variability in SCZ is higher than that in an unaffected control (CTL) group. Specifically, we applied the test for equality of variances to the normalized expression data generated by the CommonMind Consortium (CMC) and identified 87 genes with significantly higher expression variances in the SCZ group than the CTL group. One of the genes with differential variability, VEGFA , encodes a vascular endothelial growth factor, supporting a vascular-ischemic etiology of SCZ. We also applied a Mahalanobis distance-based test for multivariate homogeneity of group dispersions to gene sets and identified 19 functional gene sets with higher expression variability in the SCZ group than the CTL group. Several of these gene sets are involved in brain development (e.g., development of cerebellar cortex, cerebellar Purkinje cell layer and neuromuscular junction), supporting that structural and functional changes in the cortex cause SCZ. Finally, using expression variability QTL (evQTL) analysis, we show that common genetic variants contribute to the increased expression variability in SCZ. Our results reveal that SCZ brains are characterized by overdispersed gene expression, resulting from dysregulated expression of functional gene sets pertaining to brain development, necrotic cell death, folic acid metabolism, and several other biological processes. Using SCZ as a model of complex genetic disorders with a heterogeneous etiology, our study provides a new conceptual framework for variability-centric analyses. Such a framework is likely to be important in the era of personalized medicine. (313 words)

Commonality in Dysregulated Expression of Gene Sets in Cortical Brains of Individuals with Autism, Schizophrenia, and Bipolar Disorder

Two Gene Co-expression Modules Differentiate Psychotics and Controls

Overdispersed Gene Expression in Schizophrenia

Disease similarity network analysis of Autism Spectrum Disorder and comorbid brain disorders

Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology

Shared and Cell-Type-Specific Gene Expression Patterns Associated with Autism Revealed by Integrative Regularized Non-Negative Matrix Factorization

Shared genetic architecture of cortical thickness alterations in major depressive disorder and schizophrenia

A Combined Analysis of Genome-Wide Expression Profiling of Bipolar Disorder in Human Prefrontal Cortex.

Immune signature of gene expression pattern shared by autism spectrum disorder and Huntington's disease

Investigating the Shared Genetic Architecture Between Psychiatric Disorders and Executive Function

Cortical gene expression architecture links healthy neurodevelopment to the imaging, transcriptomics, and genetics of autism and schizophrenia

Shared Molecular Neuropathology Across Major Psychiatric Disorders Parallels Polygenic Overlap

Overdispersed gene expression characterizes schizophrenic brains

Exploiting Aberrant Mrna Expression in Autism for Gene Discovery and Diagnosis

Putative psychosis genes in the prefrontal cortex: combined analysis of gene expression microarrays

Integrative Analysis of Genome-Wide Association Studies Identifies Novel Loci Associated with Neuropsychiatric Disorders

Varying Mutational Classes Illuminate Differential Genetic Patterns Between Schizophrenia and Bipolar Disorder

Transcriptomics Analysis Reveals Shared Pathways in Peripheral Blood Mononuclear Cells and Brain Tissues of Patients With Schizophrenia

Uncovering convergence and divergence between autism and schizophrenia using genomic tools and patients' neurons

Spatial Expression Pattern of ZNF391 Gene in the Brains of Patients with Schizophrenia, Bipolar Disorders or Major Depressive Disorder Identifies New Cross-Disorder Biotypes: A Trans-Diagnostic, Top-Down Approach

Overlapping Genetic Architecture Between Schizophrenia and Neurodegenerative Disorders